Moderna COVID vaccine could be up to 94.5% effective, seeks FDA authorization l GMA
The new sign of hope comes as the U.S. topped 11 million cases and states have forced measures like a home advisory in Chicago and a mask mandate in North Dakota.
COVID-19 vaccines from Pfizer Inc and Moderna Inc could be ready for United States authorisation and distribution within weeks, setting the stage for inoculation to begin as soon as this year, US Health and Human Services Secretary Alex Azar said on Wednesday.
Pfizer says it will request an emergency use authorisation from the US Food and Drug Administration for its COVID-19 vaccine in the coming days.
It has shown consistent results across broad demographics with no major side effects.
Al Jazeera's Gabriel Elizondo reports from New York. Dr. Anthony Fauci tells CNN's Jake Tapper that a coronavirus vaccine could be available to all Americans by April, 2021. AstraZeneca said its Covid-19 vaccine could be up to 90 percent effective in preventing the disease — a third breakthrough in the fight against the pandemic. Dr. John Torres explains why AstraZeneca's vaccine not needing cold storage is important, and how long a vaccine will likely keep recipients protected against the virus. AstraZeneca said on Monday that its Covid-19 vaccine could be up to 90 percent effective in preventing the disease — the third promising breakthrough in the fight against a pandemic that has killed nearly 1.4 million people worldwide. Aired on 11/23/2020.